Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
38 participants
INTERVENTIONAL
2022-04-11
2025-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Self Regulation With Mindfulness Training on Body Mass Index and Cardiovascular Risk Markers in Obese Adults
NCT01375504
Optimizing Self-Monitoring Feedback for the Treatment of Obesity
NCT06508580
Effects of Inhibitory Control Training in Eating Behaviors
NCT03599115
The Role of a Virtual Coach in Improving Adherence to an Activity Program for Overweight Adults
NCT00792207
Video Conferencing and In-person Health Coaching on Weight Loss, Physical Activity, and Metabolic Control
NCT03278951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Additional Follow-up
In addition to receiving an ActiGraph activity monitor, participants will complete weekly phone/zoom calls with research staff for a more in-depth monitoring of their activity level.
Phone/zoom calls
Participants will complete weekly follow-up phone/zoom calls with a member of the research team. The phone/zoom calls will typically last 30-60 minutes. Participants will discuss barriers to activity and goals for upcoming weeks.
Activity Level Monitoring
Participants receive an ActiGraph activity monitor to track their activity level over a 6-week period.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phone/zoom calls
Participants will complete weekly follow-up phone/zoom calls with a member of the research team. The phone/zoom calls will typically last 30-60 minutes. Participants will discuss barriers to activity and goals for upcoming weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI greater than or equal to 40
* Sit or lie down greater than or equal to 9 hours per day
Exclusion Criteria
* Participating in a formal weight loss or exercise program
* Planning to join a formal weight loss or exercise program in the next 2 months
* Cannot stand up without assistance
* Currently pregnant
* Planning to get pregnant in the next 2 months
* Given birth in past 9 months
* Currently breast feeding
* Weigh over 400 lbs
* Highest level of education is below 8th grade
* PHQ-9 score less than 15
* Visual impairment that impairs ability to read
* Any condition(s) that would make it challenging to follow instructions/directions
* Cognitive disorder (e.g., dementia)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charles Emery PhD
Professor and Department Chair
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Emery, PhD
Role: PRINCIPAL_INVESTIGATOR
Cardiopulmonary Behavioral Medicine at OSU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021B0332
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.